FDA Approved: LEQVIO — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for LEQVIO (inclisiran) submitted by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• LEQVIO (inclisiran)

Snippet

SUPPL AP for LEQVIO (INCLISIRAN)